ئەز   Husham Yousuf Mohammed Ali Bayazed


Professor

Specialties

Medical Immunology & Microbiology

Education

Doctor of Philosophy Immunology

College of Medicine / Uuniversity of Mosul / iRAQ لە College of Medicine / Uuniversity of Mosul / iRAQ

2006

Master of Science Immunology

Immunology & Microbiology لە College of Medicine / Uuniversity of Mosul / iRAQ

1980

Bachelor in Medicine & Surgery

Medicine & Surgery لە College of Medicine / Uuniversity of Mosul / iRAQ

1980

Membership


2013

2013-10-23,current
membership

Membership of American Association of Science & Technology

2013-09-24,current
Membership

Membership of Metabolomics Society (USA)

2009

2009-08-11,current
Membership

Membership member of the World Stroke Organization

2009-05-10,current
Membership

Fellowship member of ISC (International Society of Chemotherapy, Infections and Cancer),

2008

2008-06-16,current
Membership

Immunologist's Advisory Board Member (EUROMDnet), Brussels, Belgium

2004

2004-02-10,current
Membership

Member of the Arab Alliance for the Prudent Use of Antimicrobials (ArAAPUA)

Academic Title

Professor

2008-05-19

Ass. Professor

1993-09-22

Lecturer

1990-07-25

Ass. lecturer

1987-03-18

Published Journal Articles

Journal of Applied Biology and Biotechnology (Issue : 2) (Volume : 6)
Assessment of chlorine resistant bacteria and their susceptibility to antibiotic from water distribution system in Duhok province

Chlorination has been the most widely practiced method of disinfection for potable waters since the... See more

Chlorination has been the most widely practiced method of disinfection for potable waters since the turn of the century and principal means by which the microbial quality of water is maintained in Iraq. Khabur river is the main source of our drinking water in Zahko-Duhok city, here chlorine in form of hypochlorous at concentration 2 ppm are most used. In this paper, we have attempted to compare the sensitivity of microorganisms toward chlorine and also we have tried to the determination of chlorine resistant bacteria to antibiotics. Results from our experiment suggest that bacteria isolated from post-chlorinated water samples are more resistant to chlorine disinfection than prechlorinated water samples. the isolated organisms are Staphylococcus aureus, Micrococcus variants and Aeromonas hydrophila fully resistant to chlorine at this concentration and the most resistant bacterium of all isolates is Staphylococci. Although the strains were sensitive to abroad spectrum of antibiotics the strains show resistant to the most important clinical antibiotics. The suggestion that either the synthesis of unique proteins or aggregation of the bacteria as mechanisms of resistance to inactivation. This study will help us to suggest relevant changes in purification processes for the supply of better quality of drinking water to our Municipal Corporation.

 2014-11
Journal of immunotoxicology (Issue : 2) (Volume : 9)
Concentration levels of IL-10 and TNFα cytokines in patients with human papilloma virus (HPV) DNA+ and DNA− cervical lesions

The present study was performed to assess the immune response in women with human papilloma... See more

The present study was performed to assess the immune response in women with human papilloma virus (HPV) DNA+ and DNA− cervical lesions. Eighty women with cervical lesions (age range = 25–70 years) and 20 healthy individuals (control group) were enrolled in the study. Lesions were cytologically classified into four groups: ASC-US (20), CINI (30), CINII-III (16), and cervical carcinoma (14) prior to HPV DNA detection. Estimation of interleukin (IL)-10 and tumor necrosis factor (TNF)-α levels in cervical secretions and serum of the studied patients was performed utilizing ELISA. PCR screening kits were used to detect HPV DNA in cervical smears obtained from the studied cases with the different lesions. IL-10 levels in cervical secretions of HPV DNA+ were significantly greater than those from DNA− patients (i.e., 88.73 vs 24.00 pg/ml) and from controls (i.e., 88.73 vs 8.27 pg/ml) and the levels were higher in DNA− patients than in controls (i.e., 24.00 vs 8.27 pg/ml). In comparison, serum IL-10 levels in these patients did not significantly differ from control values (i.e., 13.69 vs 12.16 vs 9.99 pg/ml, respectively). TNFα levels in cervical secretions of the HPV DNA+ and DNA− cases did not significantly differ from values for the controls (i.e., 12.18 vs 9.90 vs 7.90 pg/ml, respectively). Serum TNFα of these patients also did not differ significantly from controls (i.e., 11.59 vs 11.90 vs 10.83 pg/ml, respectively). The detected levels of IL-10 in cervical secretions of patients with HPV DNA+ lesions was significantly higher than in their sera, while secretion TNFα levels were nominally greater than sera values. Lastly, higher levels of IL-10 were observed in secretions of 10–14 (71.4%) patients who had progressive cervical lesions (HSIL and cervical cancer stages) who were HPV DNA+ than observed in 20 of 66 (30.0%) of DNA− patients with similar progressive lesions. In general, the higher levels of IL-10 than of TNFα suggested a potential down-modulation of tumor-specific immune responses to HPV-infected lesions. This phenomenon appears to provide a tumor ‘progressive’ microenvironment in these particular patients.

 2012-04
European Journal of Cancer (Issue : 4) (Volume : 48)
AOS4 Detection of human papillomavirus DNA in patients with different cervical lesions in Kurdistan region, Iraq

Background Human papillomavirus (HPV) is documented to be a causative agent of cervical cancer and... See more

Background Human papillomavirus (HPV) is documented to be a causative agent of cervical cancer and detection rates of more than 90% were registered in some parts of the world. This study was undertaken to introduce polymerase chain reaction (PCR) for diagnosing HPV infection in women with different cervical lesions for the first time in Kurdistan region and to define the most prevalent high-risk (HR) genotypes (HR HPV). Methods Eighty women (aged 25–70 years) with different cervical lesions, cytologically classified as ASC-US (n = 20), CINI (n = 30), CINII-III (n = 16), and cervical carcinoma (n = 14) and 20 healthy individuals (control group) were enroled in this study. PCR screening kits were used to extract the entire genomic DNA from cervical cells scraped from cases and then PCR HR HPV genotyping kits were used to test the positive samples. Findings HPV DNA was detected at an estimated rate of 17.5% in the cases but was absent in the control group. In the cases, the detection rate of HPV DNA was 1.25% (1 of 20), 3.75% (3 of 30), 5.0% (4 of 16), and 7.5% (6 of 14) in the cytological categories ASC-US, LSIL (CIN-I), HSIL (CIN-II–III), and cervical cancer, respectively. Moreover, the results of this study showed the detection of seven HR HPVs 16, 52, 56, 35, 45, 39, and 33 at frequency rates of 28.4%, 21.4%, 14.3%, 14.3%, 7.1%, 7.1%, and 7.1%, respectively. Therefore, HPV 16 was the most commonly detected HR HPV genotype among the positive cases (28.4%). Interpretation This is the first PCR study done in the Kurdistan region. The detected rate of HPV DNA (17.5%) in this region verifies the use of PCR. Moreover, the detected rate of HPV infection correlated with the severity of the cytological findings and HPV 16 was the most commonly detected HR genotype among positive cases (28.4%). Knowing the rate of HPV infections and the HR genotypes are of utmost importance for HPV vaccine introduction, which is not yet scheduled in this region and other parts of Iraq.

 2012-04
Journal of Immunotoxicology (Issue : 2) (Volume : 5)
Anti-β2-Glycoprotein I Autoantibody Expression as a Potential Biomarker for Strokes in Patients with Anti-Phospholipid Syndrome

Anti-phospholipid syndrome (APS) is an autoimmune disease. Cerebral ischemia associated with APS occurs at a... See more

Anti-phospholipid syndrome (APS) is an autoimmune disease. Cerebral ischemia associated with APS occurs at a younger age than typical atherothrombotic cerebrovascular disease, is often recurrent, and is associated with high positive IgG anti-phospholipid (GPL) unit levels. This study sought to determine the frequency rates of anti-cardiolipin (aCL) dependent on the presence of β2-GPI, anti-β2-glycoprotein I (aβ2-GPI), and anti-phosphatidyl serine (aPS) IgG autoantibodies among stroke patients, and thus demonstrate the importance of testing for aβ2-GPI autoantibodies. For these study, stroke patients and control subjects recruited from Mosul, Erbil, and Dohuk provinces in Northern Iraq between March 2004 and March 2005 were evaluated. All cases were under 50 years-of-age and had no recognizable risk factors. Using ELISA to evaluate the presence of IgG isotype of aCL, aβ2-GPI, and aPS autoantibodies in their blood, the results indicated that the frequency of aβ2-GPI was 14/50 (28%), aCL was 11/50 (22%), and aPS was 9/50 (18%) among stroke patients. In contrast, aCL was detected in 2/30 (6.7%) of control subjects; each of the other anti-phospholipid antibodies (APLA) was never observed. Of all the aβ2-GPI+ cases, the incidence of stroke patients having the combined profile of aβ2-GPI + aCL was 11/14 (78.6%) and of aβ2-GPI + aPS was 9/14 (64.3%). Only 2/14 (14.3%) of these aβ2-GPI+ patients also expressed aCL in the absence of aPS. The frequency of patients expressing all three markers was only 9/14 (64.3 %). In none of the APS/stroke patients were aCL or aPS expressed in the absence of the aβ2-GPI. Conversely, aβ2-GPI as a sole marker was seen in 3/14 (21.4%) of these patients (i.e., in absence of either other marker). It can be concluded from these studies that the among the three major forms of APLA examined, the presence of aβ2-GPI IgG autoantibodies appeared to correlate best with stroke in patients who were concurrently suffering APS.

 2008-08
Sultan Qaboos University medical journal (Issue : 3) (Volume : 7)
Antiphosphatidyl Serine Autoantibodies and Premature Coronary Events

Objectives: To determine whether antiphosphatidyl serine autoantibodies (aPS) are associated with increased risk of occurrence... See more

Objectives: To determine whether antiphosphatidyl serine autoantibodies (aPS) are associated with increased risk of occurrence of coronary events in selected patients. Methods: This study compared 50 patients with coronary events with 30 controls, recruited from the cities of Mosul, Erbil, and Dohuk cities, Northern Iraq, between March 2004 and March 2005. The patient group consisted of 23 individuals with myocardial infarction and 27 with angina. We evaluated the presence of aPS antibodies (IgG and IgM isotypes) by an enzyme-linked immunosorbent assay. The studied cases were less than 50 years of age (mean ± SD, 39.6 ± 5.9) and had no recognizable risk factors. Results: The frequency of detecting IgG aPS was 10/50 (20%) among patients and 1/30 (3.3%) among controls, with a significant difference and with an adjusted odds ratio (OR) of 3.2 (95%CI, 1.1–9.1; p < 0.05). The IgM aPS frequency was 3/50 (6%) among patients and zero in the controls, with a non-significant difference. The three cases were also IgG positive (i.e. the frequency rate for detection of aPS of IgM was the same as for IgG). Moreover, this marker (aPS) was detected in 8/12 (66.7%) of cases with unstable angina, in 2/15 (13.3%) with stable angina, and in none of the cases with myocardial infarction. Conclusion: IgG aPS autoantibodies are associated with increased risk of coronary events especially angina of unstable subset.

 2007-12
Qatar Medical Journal (Issue : 2) (Volume : 15)
The Role of Anti-Phospholipid Auto Antibodies Syndrome in Cerebrovascular Diseases Read More: http://www.qscience.com/doi/abs/10.5339/qmj.2007.2.15

Objectives: The aims of the study are to determine the role of anti-phospholipid autoantibodies (APLAs)... See more

Objectives: The aims of the study are to determine the role of anti-phospholipid autoantibodies (APLAs) among patients with stroke and/or transient ischaemic attacks (TIAs), to identify the types and effective isotype of some important APLAs which are lupus anticoagulant (LA), anticardiolipin (aCL), anti∼fi2 glycoprotein I dependent (afi2-GPI), and anti-phosphatidyl serine (aPS). Also, to find out any concomitant effect of non-APLAparameters not specific to antiphospholipid syndrome (APS). Subjects and Methods: This study was carried out on 50 patients attending mainly the Teaching and General Hospitals in Mosul, Duhok, and Erbil Cities, Iraq during the period between 1st March 2004 and 1st March 2005. The studied cases were under 50 years of age, and had no recognizable risk factors. The activated partial thromboplastin time (APTT) was used for LA estimation and ELISA assay was used to test for IgG& IgM isotypes ofaCL, aJ32-GPI, and aPS. The ANA, RF, VDRL, CRP, and C4 complement were tested by different immuoserological methods. The thrombocytopenic (TP) status was diagnosed by estimation of platelets counts. Results: The strokes and!or TIAs related to APS were diagnosed in 22/50 (44%) of patients and a significant correlation was reported among patients with IgG plus IgM aCL (p < 0.05), IgG afi2-GPI (p < 0.05), and IgG aPS (p < 0.05). In APLAs positive patients, raised CRP concentrations were reported in 36.4%, TP status in 22.7%, ANA in 22.7%, RF positive in 13.6%, and low C4 levels in l3.6%. Finally, the FP-VDRL test was found in 50 % of APLAs positive cases. Conclusions: The aCL, afi2- GPI, and aPS antibodies were shown to play a significant role in the development of stroke and!or TIAs among the studied cases. Read More: http://www.qscience.com/doi/abs/10.5339/qmj.2007.2.15

 2007-11
JOURNAL-BAHRAIN MEDICAL SOCIETY (Issue : 1) (Volume : 19)
The prevalence of Antiphospholipid Autoantibodies in Patients with Deep Venous Thrombosis

The prevalence of Antiphospholipid Autoantibodies in Patients with Deep Venous Thrombosis

 2007-02
EMHJ - Eastern Mediterranean Health Journal (Issue : 1) (Volume : 10)
Hepatitis B infection among Iraqi children: the impact of sanctions

Effect of sanctions on hepatitis B vaccine availability and occurrence of viral hepatitis B among... See more

Effect of sanctions on hepatitis B vaccine availability and occurrence of viral hepatitis B among Iraqi children was studied. Between June 2000 and June 2001, families of patients attending the Public Health Laboratory, Mosul, for hepatitis B follow-up were screened. Enzyme-linked immunosorbent assay was used to test for HBsAg, HBeAg and anti-HBe. We diagnosed 74 children born 1994-1998 as HBsAg carriers. For 62 of 74 cases, parents had consulted vaccine centres promptly: 41 were not vaccinated and 21 had only one vaccine dose. HBeAg marker was positive for 9 [‎14.5%]‎ and anti-HBe for 50 [‎80.7%]‎. Parental reluctance was the reason for non-vaccination for 12. Vaccine shortages during the birth years of cases were documented, even after implementation of United Nations Security Council Resolution 986

 2004-04
JOURNAL-BAHRAIN MEDICAL SOCIETY (Issue : 1) (Volume : 16)
Oral Candidiasis (Thrush) in Debilitated Children in North Iraq

Different species of Candida Albicans and non-Albicans were isolated among children with different debilitating diseases.

 2004-02
Saudi Medical Journal (Issue : 9) (Volume : 24)
Trial of lamivudine in hepatitis B surface antigen carriers with persistent hepatitis B core IgM antibody.

OBJECTIVES The persistence of hepatitis B core immunoglobulin M (HBc IgM) antibody in hepatitis B... See more

OBJECTIVES The persistence of hepatitis B core immunoglobulin M (HBc IgM) antibody in hepatitis B surface antigen (HBsAg) carriers is a risk factor with hidden dangers and forecasts the existence of liver damage. A trial of lamivudine in such subset of carriers was carried out for the first time in this study. METHODS A total of 62 HBsAg with hepatitis e antibody individuals (age range, 25-45 years) with persistent HBc IgM antibody were randomized to receive either 100 mg lamivudine (32/62) or placebo (30/62) daily for 6 months. The study was performed from June 2000 to October 2002. The carriers were regular attendees of the Virology Center in Mosul, North Iraq for follow up. Enzyme-linked immunosorbent assay technique was performed to detect the different hepatitis B virus markers. RESULTS Among the lamivudine group, HBc IgM antibody seroclearance achievement rate was 81.3% and HBsAg seroconversion rate was 9.4% compared to 6.3% and 3.3% in the placebo group. Number of adverse clinical events were observed, but were of mild nature and tolerable by the participants who completed the study. CONCLUSIONS The trial of lamivudine in this subset of HBsAg carriers proved to be safe and efficacious. More studies are needed prior to recommending the drug for routine use on selected HBV carriers.

 2003-06
Saudi Medical Journal (Issue : 7) (Volume : 23)
Clinical and prognostic values of anti-hepatitis B core immunoglobulin M detection in asymptomatic hepatitis B surface antigen carriers.

OBJECTIVES The aim of this study is to evaluate the clinical and prognostic values of... See more

OBJECTIVES The aim of this study is to evaluate the clinical and prognostic values of persistence of anti-hepatitis B core immunoglobulin M antibody in asymptomatic adults chronic hepatitis B surface antigen anti-hepatitis Be carriers and its absence in others. METHODS Fifty-two hepatitis B surface antigen/anti-hepatitis Be carriers with and 32 without anti-hepatitis B core immunoglobulin M marker were enrolled in this study. The cases were regular attendees of Public Health Laboratory, Virology Center (the main referral center for viral hepatitis) Mosul, North Iraq, for follow-up and clinical evaluation. The study was performed from June 1999 to June 2001. The studied groups consisted of adults, with mean age of 35.5 year (standard deviation +/- 10). The results of histological findings of 23 carriers with and 12 carriers without anti-hepatitis B core immunoglobulin M who underwent liver biopsy were added to the study. Micro enzymed-linked immunosorbent assays was utilized to detect hepatitis B virus markers. RESULTS Existence of carrier in the family was significantly associated with persistence of anti-hepatitis B core immunoglobulin M in the studied individuals (p<0.005, odds ratio = 7.4; 95% confidence interval = 1.8 to 38.0), as was the case in the presence of family history of acute hepatitis (p<0.05, odds ratio = 4.6; 95% confidence interval = 4.6 to 21.2). The detection of this antibody was significantly associated with the presence of abnormal liver histology compared to carriers without this antibody (p<0.01, odds ratio = 7.2; 95% confidence interval = 1.8 to 28.7). The study revealed that clustering of carrier cases existed in statistically significant (p<0.001) pattern in family members of carriers with anti-hepatitis B core immunoglobulin M. CONCLUSIONS The detection of anti-hepatitis B core immunoglobulin M clinically is a reminder of recent exposure to the virus through different routes, mainly intrafamilial. Ongoing liver changes are observed in the majority of carriers with this antibody indicating the viral activity, albeit in a silent manner, but earlier progress to serious liver sequels may be inevitable. Foretelling that carriers with anti-hepatitis B core immunoglobulin M are more infectious than carriers without this marker is ascertained by the existence and clustering of carrier cases amongst their family members.

 2002-09
JOURNAL-BAHRAIN MEDICAL SOCIETY (Issue : 3) (Volume : 13)
Adult HBsAg carriers: The possible risk to the carriers, family members, and the community

Adult HBsAg carriers: The possible risk to the carriers, family members, and the community

 2002-04
Qatar Medical Journal (Issue : 2) (Volume : 10)
Prevalence of Hepatitis B & D viral infections among hospital personnel in Mosul

Different immunological viral markers of HBV and HDV were detected....

 2001-09
Ann. Coll. Med. Mosul (Issue : 2) (Volume : 27)
Prevalence of Cytomegalovirus Infection among Leukemic Patients in Mosul, Iraq.

Prevalence of Cytomegalovirus Infection among Leukemic Patients in Mosul, Iraq

 2001-03
EMHJ - Eastern Mediterranean Health Journal (Issue : 5) (Volume : 5)
Follow-up of pregnant women with active cytomegalovirus infection

Pregnant women [‎60]‎ with and without serological evidence of active cytomegalovirus [‎CMV]‎ infection were followed... See more

Pregnant women [‎60]‎ with and without serological evidence of active cytomegalovirus [‎CMV]‎ infection were followed until delivery to detect the incidence and types of overt congenital CMV infection in neonates in Mosul, Iraq. Infection was diagnosed by the detection of CMV-IgM, using ELISA. CMV-IgM was detected in cord blood samples of six [‎10%]‎ overtly sick infants [‎with different congenital malformations]‎ born to mothers with active CMV infection. Central nervous system abnormalities were detected in all six cases [‎two with microcephaly and four with hydrocephaly]‎. Congenital CMV infection should be suspected in infants born with congenital malformations, especially those of the central nervous system. The detection of a significant number of hydrocephalus cases in our study is notable

 1999-02
Jordan Medical Jjournal (Issue : 1) (Volume : 29)
Congenital cytomegalovirus infection among newborn infants with different congenital anomalies

Congenital cytomegalovirus infection among newborn infants with different congenital anomalies

 1995-04
Jordan Medical Jjournal (Issue : 1) (Volume : 26)
Prevalence of cytomegalovirus infection in childbearing age women in Mosul, IRAQ.

Prevalence of cytomegalovirus infection in childbearing age women in Mosul, IRAQ

 1992-05
Qatar Medical Journal (Issue : 1) (Volume : 7)
The frequency of HSV Types 1&2 infections in women with herpes-like genital lesions.

The frequency of HSV Types 1&2 infections in women with herpes-like genital lesions

 1988-02

Thesis

2008-05-14
Antiphospholipids Autoantibodies Among Patients with Different Cardio-cerebrovascular Diseases.

Antiphospholipids Autoantibodies Among Patients with Different Cardio-cerebrovascular Diseases.

 2008
1987-07-17
Prevalence of Hepatitis B & D Viral Infections Among Hospital Personnel: clinico-immunological study

Prevalence of Hepatitis B & D Viral Infections Among Hospital Personnel: clinico-immunological study

 1987

Conference

Second International Meeting on Gynecology & Obstetric Pathology, November 19-20 / 2018, Paris / France.
 2018-11
Concentration levels of IL-10 and TNFα cytokines in patients with human papilloma virus (HPV) DNA+ and DNA− cervical lesions

Concentration levels of IL-10 and TNFα cytokines in patients with human papilloma virus (HPV) DNA+ and DNA− cervical lesions

Molecular and Cancer Biomarker, September 15-18, 2016, Berlin / Germany
 2016-09
Detection of human papillomavirus DNA in patients with different cervical lesions in Kurdistan Region, Iraq

Detection of human papillomavirus DNA in patients with different cervical lesions in Kurdistan Region, Iraq

World Congress and Expo on Applied Microbiology, August 18-20, 2015, Frankfurt / Germany.
 2015-08
Primary cutaneous actinomycosis: The first case report in Kurdistan /Iraq

Primary cutaneous actinomycosis: The first case report in Kurdistan /Iraq

World Congress and Expo on Applied Microbiology, August 18-20, 2015, Frankfurt / Germany.
 2015-08
Primary cutaneous actinomycosis: The first case report in Kurdistan /Iraq

Primary cutaneous actinomycosis: The first case report in Kurdistan /Iraq

The 15th World Congress of Cervical Pathology and Colposcopy (IFCPC-2014), 26-30 May 2014, London UK
 2014-05
Immune Microenvironment of DNA+ and DNA− Cervical Lesions Among Infected Patients with Human Papillomavirus (HPV)

Immune Microenvironment of DNA+ and DNA− Cervical Lesions Among Infected Patients with Human Papillomavirus (HPV)

The 15th International Conference of Immunology. August 22-27, 2013 Milan Italia
 2013-08
Anti-β2-Glycoprotein I Autoantibody Expression as a Potential Biomarker for Strokes in Patients with Anti-Phospholipid Syndrome

Anti-β2-Glycoprotein I Autoantibody Expression as a Potential Biomarker for Strokes in Patients with Anti-Phospholipid Syndrome

The "World Congress of Gastroenterology & Urology" March 14-16, 2012. Omaha USA
 2012-03
Prevalence of Hepatitis B & D Viral Infections Among Hospital Personnel: clinico-immunological study

Prevalence of Hepatitis B & D Viral Infections Among Hospital Personnel: clinico-immunological study

The 18th Asian – Pacific Congress of Cardiology, 5-8 May 2011, Kuala Lumpur, Malaysia.
 2011-05
Antiphospholipd Autoantibodies Among Patients with Cardio-cerebrovascular Diseases

Antiphospholipd Autoantibodies Among Patients with Cardio-cerebrovascular Diseases

The " Prague Hepatology Meeting" Sep 16-18 2010. Prague, Czech Republic
 2010-09
Prevalence of Hepatitis B & D Viral Infections Among Hospital Personnel: clinico-immunological study

Prevalence of Hepatitis B & D Viral Infections Among Hospital Personnel: clinico-immunological study

The 26th International Congress of Chemotherapy & Infection, June 18-21 2009. Toronto-Canada
 2009-06
Primary cutaneous actinomycosis: The first case report in Kurdistan /Iraq

Primary cutaneous actinomycosis: The first case report in Kurdistan /Iraq

The 2nd World Conference on Magic Bullets. Oct 3-5 2008. Nürnberg, Germany
 2008-10
Primary cutaneous actinomycosis: The first case report in Kurdistan /Iraq

Primary cutaneous actinomycosis: The first case report in Kurdistan /Iraq

The 6th Stroke Congress. Sep 24-27th 2008. Austria, Vienna
 2008-09
Anti-β2-Glycoprotein I Autoantibody Expression as a Potential Biomarker for Strokes in Patients with Anti-Phospholipid Syndrome

Anti-β2-Glycoprotein I Autoantibody Expression as a Potential Biomarker for Strokes in Patients with Anti-Phospholipid Syndrome

The 2nd International Conference on Hypertension, Lipids, Diabetes & Stroke Prevention. March 6-8 2008. Prague, Czech Republic
 2008-03
Anti-β2-Glycoprotein I Autoantibody Expression as a Potential Biomarker for Strokes in Patients with Anti-Phospholipid Syndrome

Anti-β2-Glycoprotein I Autoantibody Expression as a Potential Biomarker for Strokes in Patients with Anti-Phospholipid Syndrome

The Second Immune-Mediated Diseases Congress, Sep 10-15th 2007. Moscow / Russia
 2007-09
Antiphospholipd Autoantibodies Among Patients with Cardio-cerebrovascular Diseases

Antiphospholipd Autoantibodies Among Patients with Cardio-cerebrovascular Diseases

The 25th International Pediatric Congress, August 25-30th 2007. Athens/ Greece
 2007-08
Oral Candidiasis (Thrush) in Debilitated Children in North Iraq

Oral Candidiasis (Thrush) in Debilitated Children in North Iraq

The 29th Mediterranean and Middle East Pediatric Societies, Sep 13-17 2005. Istanbul-Turkey
 2005-09
Oral Candidiasis (Thrush) in Debilitated Children in North Iraq

Oral Candidiasis (Thrush) in Debilitated Children in North Iraq

The Third Arab Symposium for Antimicrobial Agents, March 25 -27th 2004. Cairo, Egypt.
 2004-03
Prevalence of Hepatitis B & D Viral Infections Among Hospital Personnel: clinico-immunological study

Prevalence of Hepatitis B & D Viral Infections Among Hospital Personnel: clinico-immunological study

Presentation

Montana Hall / Zakho/ Kurdistan Sponsored by Pioneer Drug Company
2019-01
Leukotriene Modifiers: Add - On or Stepdown treatment in childhood asthma and allergy

Sponsored by Pioneer Drug Company

 2019
Rizgare Teaching Hospital Erbil/ Kkurdistan
2018-05
Immuno-oncology & Immunotherapy

Lecture to Oncology Board Students of Medical Society of Kurdsitan (KBMS)

 2018
Rixos Hotel / Duhok / Kurdistan
2018-04
Fetal Immunity and Atopic March

Sponsored by Danone Nutricia in Collaboration with Kurdistan Paediatric Society

 2018
Bronchial Asthma Symposium- Zakho Teaching Hospital 15/2/2018 (speaker).
2018-02
Asthma Phenotyes and Endotypes

Asthma Phenotypes and Endotypes

 2018
Zakho Teaching Hospital / Zakho / Kurdistan
2017-05
Vitamin D Conundrum in Rheumatology: The Immunological Noncalcemic Face

Rheumatic Diseases: management and diagnosis symposium

 2017
Zakho Teaching Hospital / Zakho / Kurdistan
2017
Thyroid Gland & The Immune System: the obscure truth

Thyroid Diseases Symposium

 2025
Azadi Teaching Hospital Duhok / Kurdistan
2004
HBV Infection: clinical and serological interpretation of viral profiles, Azadi Hospital, Duhok 2007

Seminar: HBV Infection: clinical and serological interpretation of viral profiles

 2025
Zakho Teaching Hospital / Zakho / Kurdistan
2015-11
AUTOIMMUNE DIABETES MELLITUS

World Diabetes Day symposium, 16/11/2017

 2015
University of Zakho / Kurdistan
2014-10
Ebola Outbreaks: panic fear. Seminar University of Zakho

Seminar: Ebola Outbreaks: panic fear.

 2014
University of Zakho / Kurdistan
2014-04
Body Detoxing: is it a Myth or a Fact?

Seminar: Body Detoxing: is it a Myth or a Fact?

 2014
University of Zakho / Kurdistan
2013-11
Metabolomics: Definition, Society, Analytical Technologies, and Applications

Seminar: Metabolomics: Definition, Society, Analytical Technologies, and Applications

 2013
Zakho Technical Institute / Zakho / Kurdistan
2011-12
"Planning for Interactive Lecture" a seminar to the Scientific Staffs of Technical Institute-Zakho 5 Dec 2011

Seminar: "Planning for Interactive Lecture" a seminar to the Scientific Staffs of Technical Institute-Zakho

 2011
Zakho Technical Institute / Zakho / Kurdistan
2010-12
H1N1 Influenza pandemic: viral and epidemiological characteristics

Seminar: H1N1 Influenza pandemic: viral and epidemiological characteristics

 2010
Zakho Technical Institute / Zakho / Kurdistan
2009-12
Brucellosis: clinical stigmata, diagnosis, and treatment.

Seminar: Brucellosis: clinical stigmata, diagnosis, and treatment.

 2009
Azadi Teaching Hospital Duhok / Kurdistan
2007-05
HBV Infection: clinical and immunological Interpretation of viral profiles, Azadi Hospital, Duhok 2007

HBV Infection: clinical and immunological Interpretation of viral profiles

 2007
College of Medicine / Univeristy of Mosul / IRAQ
2002-04
Vaccinations and future prospects.

Seminar Vaccinations and future prospects

 2002
College of Medicine / Univeristy of Mosul / IRAQ
2001-04
Microbiological Parameters in Clinical Diagnosis.

Microbiological Parameters in Clinical Diagnosis.

 2001
College of Medicine / Univeristy of Mosul / IRAQ
2000-04
Microbiological and Immunological aspects of Skin Diseases.

Microbiological and Immunological aspects of Skin Diseases.

 2000
College of Medicine / Univeristy of Mosul / IRAQ
1997-05
Cow Mad and Creutzfeldt-Jakob Diseases.

Cow Mad and Creutzfeldt-Jakob Diseases.

 1997